Approval of the Patient Care Line With Rare Diseases, Brazil’s Portaria 199 and Its National Policy. What Does That Mean? What Changes?
Revista de Medicina da UFC
doi 10.20513/2447-6595.2017v57n2p6-7
Full Text
Open PDFAbstract
Available in full text
Date
August 24, 2017
Authors
Publisher
Revista de Medicina da UFC